Beth C. Vetelino

Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications

Andreas Maderna, Matthew Doroski, Chakrapani Subramanyam et al. · Journal of Medicinal Chemistry · 2014 · 130 citations

Nanotherapeutics, Lead Auristatin, Peptide Science +20

SuFEx Activation with Ca(NTf ₂ ) ₂ : A Unified Strategy to Access Sulfamides, Sulfamates, and Sulfonamides from S(VI) Fluorides

Subham Mahapatra, Cristian P. Woroch, Todd W. Butler et al. · Organic Letters · 2020 · 129 citations · Full text

Optimization of Tubulysin Antibody–Drug Conjugates: A Case Study in Addressing ADC Metabolism

L. Nathan Tumey, Carolyn A. Leverett, Beth C. Vetelino et al. · ACS Medicinal Chemistry Letters · 2016 · 70 citations · Full text

Pharmaceutical Science, Pharmaceutical Chemistry, Medicinal Chemistry +20

Design, Synthesis, and Cytotoxic Evaluation of Novel Tubulysin Analogues as ADC Payloads

Carolyn A. Leverett, Sai Chetan K. Sukuru, Beth C. Vetelino et al. · ACS Medicinal Chemistry Letters · 2016 · 37 citations · Full text

Medicinal Chemistry, Novel Tubulysin Analogues, Pharmaceutical Science +15

Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability

Martin Pettersson, Douglas S. Johnson, John M. Humphrey et al. · ACS Medicinal Chemistry Letters · 2015 · 32 citations · Full text

Align Potency, Chemical Biology, Pharmaceutical Chemistry +18